Targeted B2B peptide supplier Phoenix Pharmaceuticals operates as a B2B peptide wholesaler with in-house ELISA kits, peptides, antibodies, and custom peptide synthesis, offering a full kit of preclinical research supplies to academic labs and biotech/pharma firms. Potential sales opportunity: position comprehensive peptide and assay solutions for customers pursuing drug development and preclinical programs.

Silicon Valley manufacturing All products are manufactured in a Silicon Valley laboratory, signaling strong quality control and potential for scalable production partnerships. Sales angle: emphasize reliability, rapid lead times, and potential collaboration for scale-up or custom manufacturing projects.

Growing revenue band Revenue is in the 10 to 25 million range with a small to mid-sized team, indicating agility and potential for cross-sell and upsell within existing customer base, as well as expansion into adjacent product lines such as antibodies or more bespoke peptide services.

Customer base fit Primary customers are scientific researchers, academic labs, and biotech/pharma involved in preclinical research and drug development, suggesting opportunities for long-term contracts, recurring orders, and preferred supplier programs with emphasis on reliability and quality.

Competitive positioning In a market with major players like GenScript, Bio-Rad, Abcam, and Thermo Fisher, there is room to differentiate through niche expertise in custom peptide synthesis, tailored ELISA kits, and rapid customization, presenting a path for targeting mid-market labs seeking specialized capabilities.